Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to offer lung cancer screenings to smokers who
want to change their smoking behaviors. All eligible participants will receive smoking
cessation counseling and may be offered at least one form of smoking cessation drug.
Different forms of counseling (the delivery of counseling and access to counseling) will be
compared.
This is an investigational study. Participants on this study will not be prescribed smoking
drugs directly by the study staff. However, participants in this study may or may not receive
smoking cessation drugs, depending on what the provider thinks is in the participants best
interest. All smoking cessation drugs being used are FDA approved and commercially available.
It is investigational to compare the different forms of counseling participants receive.
Up to 1260 participants will be enrolled in this study. All will take part at MD Anderson.